Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis

Table 3 Brief summary of published studies: Transjugular intrahepatic portosystemic shunt for malignant portal vein obstruction n (%)

Ref.	Type of paper	Technical success rate	Stent used in TIPS	Shunt dysfunction	Indication of TIPS	Localization of PVTT	Prognosis
Chung et al[17]	Case report	6 (100)	Bare stent	2 (33)	Recurrent variceal bleeding (n = 6)	Portal trunk (n = 6)	3 patients died at postoperative month 4
Wallace et al[18]	Case series	37 (97)	Bare stent	44%	Variceal hemorrhage (n = 16), BCS (n = 3), refractory ascites/hydrothorax (n = 14), other (n = 5)	Portal trunk (n = 6), right branch (n = 5), left branch (n = 2)	30- and 90-d survival rates were 84% and 60%, respectively
Jiang et al[19]	Case series	10 (71.4)	Bare stent	NA	Intractable ascites (n = 3), simple hemorrhage (n = 1), hemorrhage and ascites (n = 10)	Portal trunk (n = 14), right branch (n = 11), left branch (n = 4)	Mean survival time 132.3 d
Burger et al[20]	Case report	2 (100)	Bare stent	0%	Recurrent variceal bleeding (n = 1), refractory ascites (n = 1)	Portal trunk (n = 2)	One patient died at postoperative month 3

BCS: Budd-Chiari syndrome; NA: Not available; PVTT: Portal vein tumor thrombosis; TIPS: Transjugular intrahepatic portosystemic shunt.